Search Results 791-800 of 25583 for treatment resistant depression
The purpose of the study is to determine the best dose of CC-486 (oral azacitidine) combined with pembrolizumab for the treatment of platinum-resistant ...
Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia · More about research at Mayo ...
Depression and anxiety after a heart attack are ... Participants who were treated ... Mayo Clinic's SCAD Research Program also is studying possible treatments for ...
Talk to your doctor if your symptoms are not improving with treatment ... Depression. Difficulty breathing can keep you ... And dealing with serious illness can ...
... treating patients with anal canal cancer that has not responded to previous treatment (refractory) and has spread to other places in the body (metastatic).
About this study. Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the ...
Mayo Clinic Comprehensive Cancer Center combines personalized cancer treatment with leading-edge research to provide you with unparalleled cancer care.
This multicenter, open-label, dose-escalating study will assess the safety and efficacy of DFRF4539A in patients with relapsed or refractory multiple myeloma.
Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer. Print ...
... Refractory Kidney Pain Rochester, MN. The purpose of this study is to examine patient reported outcomes including pain, quality of life, depression and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.